U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07025824) titled 'Randomized Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation' on June 10.
Brief Summary: The aim of this study is to compare the effectiveness and tolerability of two conditioning chemotherapies prior to allogeneic stem cell transplantation.
The following will also be investigated:
* Survival
* Remission and Relapse rate
* Engraftment or graft failure
* Graft versus Host Disease (GvHD)
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
AML - Acute Myeloid Leukemia
MDS (Myelodysplastic Syndrome)
Intervention:
DRUG: Treosul...